FDA Adverse Event Injury Summary report: N

AVALON ELITE

MDR report key: 1822463 · Received August 26, 2010

Report

Report Number
2032228-2010-00005
Event Type
Injury
Date Received
August 26, 2010
Date of Event
June 24, 2010
Report Date
August 24, 2010
Manufacturer
AVALON LABORATORIES LLC
Product Code
DWF
PMA / PMN Number
081820
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
UK
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

DEVICE HISTORY RECORD AND INSPECTION DOCUMENT (LOTS 2131608, 2131609, 2131610, AND 2131955) RELATED TO THE PRODUCT USED WAS REVIEWED AND FOUND NO NON CONFORMITIES. THE 13FR BI-CAVAL LUMEN CATHETER ARE INSPECTED 100% IN PRODUCTION. THE IFU WARNS THAT INCORRECT INSERTION CAN CAUSE DAMAGE TO THE VESSELS AND/OR HEART STRUCTURES.

Description of Event or Problem · 1

BRIEF DESCRIPTION: TETRALOGY OF FALLOT WITH PERSISTENT PULMONARY HYPERTENSION CANNULATED FOR VV ECMO BY (B)(6). CANNULA INSERTED WITH FLUOROSCOPIC GUIDANCE. NO IMMEDIATE COMPLICATION APPARENT. CANNULA APPEARED IN GOOD POSITION ON INITIAL CHEST X-RAY BUT SUBSEQUENTLY MOVED. ECHOCARDIOGRAPHY SHOWED CANNULA TIP TO BE WITHIN THE CORONARY SINUS AND WAS REPOSITIONED AND A TRIAL OFF COMMENCED AFTER 40 HOURS OF ECMO SUPPORT. AS IS OUR PRACTICE ON COMMENCING TRIAL OFF THE FLOW WAS INCREASED. THERE WAS THEN A CARDIAC ARREST AND REPEAT ECHO REVEALED A PERICARDIAL EFFUSION. REMEDIAL ACTION TAKEN AND BY WHOM UPON THE OCCURRENCE OF THE EVENT. THE CHEST WAS OPENED THROUGH A MEDIAN STERNOTOMY AND A HOLE IN THE RIGHT ATRIUM WAS IDENTIFIED JUST ANTERIOR TO THE ENTRANCE OF THE INFERIOR VENA CAVA. THIS WAS REPAIRED WITH A SINGLE PROLENE SUTURE AND AS THE PT WAS STABLE OFF ECMO THE CANNULA WAS REMOVED AND THE CHEST CLOSED. PT OUTCOME: THE PT REMAINED STABLE AND WAS DISCHARGED FROM THE HOSPITAL.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 AVALON ELITE 13 FR BI-CAVAL LUMEN CATHETER DWF AVALON LABORATORIES LLC 13 FR AVALON ELITE 090216017953

Patients

Seq Age Sex Outcome Treatment
1 2 DA Life Threatening